How to manage transfusion systems in developing countries: The Experience of Eastern and Southern Mediterranean countries.
blood transfusion systems
eastern Mediterranean
southern Mediterranean
transfusion organisation
Journal
Transfusion medicine (Oxford, England)
ISSN: 1365-3148
Titre abrégé: Transfus Med
Pays: England
ID NLM: 9301182
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
08
06
2019
revised:
21
11
2019
accepted:
23
12
2019
pubmed:
10
1
2020
medline:
13
11
2020
entrez:
10
1
2020
Statut:
ppublish
Résumé
To outline and analyse the national organisation, infrastructure and management of transfusion systems in countries sharing common historical, cultural and economic features and to decipher management trends, in order to potentially benchmark. Little is known regarding transfusion systems in Eastern/southern Mediterranean at a time international organisations are calling for the establishment of a safe and sustainable blood system. Data emanating from eight Arabic-speaking Eastern/Southern Mediterranean countries who responded to five surveys were collected and tabulated. While similarities in terms of supervision by national authorities, authorization of blood centres, quality control and management information system are evident, some significant divergence between these countries do exists. Only Lebanon does not possess a national blood establishment or organisation for blood supply. Blood components are fully government-subsidised in Algeria and Mauritania. Algeria, Morocco and Tunisia have a blood supply that relies mainly on Voluntary non-remunerated donors. Plateletpheresis is performed in all countries except Mauritania while plasmapheresis exists only in Algeria and Egypt. Morocco is the sole country outsourcing its plasma for Plasma derived products. Despite the various challenges facing these countries, lot of progresses have been made so far in the field of transfusion medicine. Yet, nationally coordinated blood programs overviewed by national regulatory authorities and actively supported by local governments are still needed to ensure the optimum level of blood safety.
Sections du résumé
OBJECTIVES
OBJECTIVE
To outline and analyse the national organisation, infrastructure and management of transfusion systems in countries sharing common historical, cultural and economic features and to decipher management trends, in order to potentially benchmark.
BACKGROUND
BACKGROUND
Little is known regarding transfusion systems in Eastern/southern Mediterranean at a time international organisations are calling for the establishment of a safe and sustainable blood system.
MATERIALS AND METHODS
METHODS
Data emanating from eight Arabic-speaking Eastern/Southern Mediterranean countries who responded to five surveys were collected and tabulated.
RESULTS
RESULTS
While similarities in terms of supervision by national authorities, authorization of blood centres, quality control and management information system are evident, some significant divergence between these countries do exists. Only Lebanon does not possess a national blood establishment or organisation for blood supply. Blood components are fully government-subsidised in Algeria and Mauritania. Algeria, Morocco and Tunisia have a blood supply that relies mainly on Voluntary non-remunerated donors. Plateletpheresis is performed in all countries except Mauritania while plasmapheresis exists only in Algeria and Egypt. Morocco is the sole country outsourcing its plasma for Plasma derived products.
CONCLUSION
CONCLUSIONS
Despite the various challenges facing these countries, lot of progresses have been made so far in the field of transfusion medicine. Yet, nationally coordinated blood programs overviewed by national regulatory authorities and actively supported by local governments are still needed to ensure the optimum level of blood safety.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-15Informations de copyright
© 2020 British Blood Transfusion Society.
Références
World Health Organization.18th WHO Model List of Essential Medicines.https://www.who.int/medicines/publications/essentialmedicines/18th_EML.pdf. Published 2013. Accessed March 9, 2019.
Darbandi A, Mashati P, Yami A, Gharehbaghian A, Namini MT, Gharehbaghian A. Status of blood transfusion in World Health Organization-eastern Mediterranean region (WHO-EMR): successes and challenges. Transfus Apher Sci. 2017;56(3):448-453.
The European Parliament and the Council of the European Union. Directive2002/98/EC of the European Parliament and of the Council of January 27, 2003. https://www.ema.europa.eu/documents/regulatory-procedural-guideline/directive-2002/98/ec-european-parliament-council-27-january-2003-setting-standards-quality-safety-collection-testing_en.pdf. Published 2003. Accessed February 27, 2019.
World Health Organization.Global status report on blood safety and availability 2016. http://apps.who.int/iris/bitstream/10665/254987/1/9789241565431-eng.pdf. Published 2016. Accessed January 30. 2019.
Markowitz MA, Waters JH, Ness PM. Patient blood management: a primary theme in transfusion medicine. Transfusion. 2014;54(10 pt 2):2587.
Ellingson KD, Sapiano MRP, Haass KA, et al. Continued decline in blood collection and transfusion in the United States-2015. Transfusion. 2015;57(suppl 2):1588-1598.
World Health Organization.Strategic framework for blood safety and availability 2016-2025. http://applications.emro.who.int/dsaf/EMROPub_2017_EN_19608.pdf?ua=1. Published 2017. Accessed January 25, 2019.
Saffi M, Howard N. Exploring the effectiveness of mandatory premarital screening and genetic counselling programmes for β-Thalassaemia in the Middle East: ascoping review. Public Health Genomics. 2015;18(4):193-203.
Solh T, Botsford A, Solh M. Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options. J Blood Med. 2015;8:219-227.
Mourad Z, Hassab H, Younan D, Abdo A. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions. Transfus Med. 2015;25(6):380-384.
Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480-487.
Bou Assi T, Haddad A, Haddad L, Garraud O. Can a decentralized blood supply system reach 100% voluntary nonremunerated donation? Int J Health Plann Manage. 2018;33(4):e883-e891.
Custer B, Zou S, Glynn SA, et al. Addressing gaps in international blood availability and transfusion safety in low- and middle-income countries: a NHLBI workshop. Transfusion. 2018;58(5):1307-1317.
Katz LM, Donnelly JJ, Gresens CJ, et al. Report of a workshop on ensuring sustainable access to safe blood in developing countries: international blood safety forum, march 24, 2017. Transfusion. 2018;58(5):1299-1306.
Ifland L, Bloch EM, Pitman JP. Funding blood safety in the 21st century. Transfusion. 2018;58(1):105-112.
Haddad A, Bou Assi T, Garraud O. How can eastern/southern Mediterranean countries resolve quality and safety issues in transfusion medicine? Front Med (Lausanne). 2018;5:45.
World Bank. http://www.worldbank.org. Published 2018. Accessed December 29, 2018.
PopulationData.net, Atlas des populations et pays du monde. https://www.populationdata.net/. Published 2018. Accessed December 29, 2018.
Garraud O, Politis C, Vuk T, Tissot JD. Rethinking transfusion medicine with a more holistic approach. Transfus Clin Biol. 2018;25(1):81-82.
Sibinga S, Cees T, John P. Transmission of HIV through blood-how to Bridge the Knowledge Gap. In: Dumais N, ed. HIV and AIDS-Updates on Biology, Immunology, Epidemiology and Treatment Strategies. London, UK: IntechOpen; 2011. http://www.intechopen.com/articles/show/title/transmission-of-hiv-through-bloodhow-to-bridge-the-knowledge-gap. Published. Accessed January 30, 2019.
World Health Organization. Availability, safety and quality of blood products.http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_20-en.pdf. Published 2010. Accessed Decemebr 29, 2018.
Tagny CT, Laperche S, Murphy EL. Francophone Africa Network for Transfusion Medicine Research. Updated characteristics of blood services, donors and blood products in 11 French-speaking African countries. Vox Sang. 2018;113(7):647-656.
World Health Organization. Summary report on Regional meeting of directors of national blood transfusion services Casablanca, Morocco May 17-19, 2016. http://www.who.int/iris/handle/10665/249541. Published 2016. Accessed February 2, 2019.
World Health Organization Regional Office for the Eastern Mediterranean. Regional status report on blood safety and availability 2016.https://apps.who.int/iris/handle/10665/258923. Published 2016. Accessed August 24, 2019.
World Health Organization. Assessment criteria for national blood regulatory systems. https://www.who.int/bloodproducts/NationalBloodRegSystems.pdf. Published 2012. Accessed January 22, 2019.
Haddad A, Bou Assi T, Ammar W, Baz E. Does a liberal national transfusion law assure blood safety? A survey of blood bank directors perspectives in Lebanon. J Public Health Policy. 2013;34(4):515-527.
Haddad A, Bou Assi T, Garraud O. Can a decentralized blood system ensure self-sufficiency and blood safety? The Lebanese experience. J Public Health Policy. 2017;38(3):359-365.
Van Hulst M, Sibinga CTS, Postma MJ. Health economics of blood transfusion safety - focus on sub-Saharan Africa. Biologicals. 2010;38(1):53-58.
Haddad A, Bou Assi T, Baz E, et al. Blood donations mode: Assessment of the Lebanese model. Transfus Clin Biol. 2019;pii:S1246-7820(19)30037-0.
WHO Expert Group. Expert consensus statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang. 2012;103(4):337-342.
World Health Organization. Towards 100% voluntary blood donation: A global framework for action. http://www.who.int/bloodsafety/publications/9789241599696/en/. Published 2012. Accessed February 2, 2019.
Ceccaldi J, Thibert JB, Haddad A, et al. Not-for-profit: a report from the fourth annual symposium of ethics held by the National Institute for blood transfusion (France). Transfus Clin Biol. 2017;24(2):76-82.
Haddad A, Bou Assi T, Haddad L, et al. Difficulties in achieving a sustainable blood supply: report from the first national seminar on blood donation in Lebanon. Eastern Mediter Health J. 2019; in press. https://doi.org/10.26719/emhj.19.070
Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S. Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion. 2010;50(2):340-343.
Allain JP. Moving on from voluntary non-remunerated donors: who is the best blood donor? Br J Haematol. 2011;154(6):763-769.
Allain JP, Sibinga CT. Family donors are critical and legitimate in developing countries. Asian J Transfus Sci. 2016;10(1):5-11.
International Societies for Blood Transfusion (ISBT). The revised code of ethics. http://www.isbtweb.org/fileadmin/user_upload/ISBT_Code_Of_Ethics_English.pdf. Published 2017. Accessed December 27, 2018.
Shuchman M. Frequent blood donors risk iron deficiency. CMAJ. 2014;186(11):817.
Schiffer C, Bohlke K, Anderson K. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update summary. J Oncol Pract. 2018;14(2):129-134.